AusperBio Therapeutics (Series B)

Funding Details

Awarder

Inbox

Date Award

May 20, 2025

Vertical

Biotechnology

Funding URL

View Funding Page

Funding Amount:

$73,000,000

---

Company Info

Company Description

AusperBio Therapeutics is a privately held clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies to achieve a functional cure for chronic hepatitis B (CHB).

Market

Chronic Hepatitis B Treatment

Location

San Francisco, California, USA

Coinvestors

HanKang Capital, Sherpa Capital, CDH Investments, Qiming Venture Partners, InnoPinnacle Fund, YuanBio Venture Capital

---

Links

• Website